Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients

American Journal of Nephrology

Volumn 17, Issue 2, 1997, Pages 146-152

  Flynn, Joseph T ^a   Kaiser, Bruce A ^a   Long, Sarah S ^a   Schulman, Seth L ^a   Deforest, Adamadia ^a   Polinsky, Martin S ^a   Baluarte, H Jorge ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Cytomegalovirus infection; Intravenous immunoglobulin G; Renal transplantation

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; SCHOOL CHILD;

EID: 0030933657     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169089     Document Type: Article

References (32)

1. Ho M: Epidemiology of cytomegalovirus infection in man: in: Cytomegalovirus: Biology and Infection, ed 2. New York. Plenum Publishing. 1991, pp 155-187.
2. Pass RF: Epidemiology and transmission of cytomegalovirus. J Infect Dis 1985:152:243-248.
3. Peterson PR, Balfour HH, Marker SC, Fryd DS, Howard RJ, Simmons RL: Cytomegalovirus disease in renal allograft recipients: A prospective study of clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore 1980:5:283-300.
4. Rubin RH: Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990; 12(suppl 7):754-766.
5. von Willebrand E, Pcttersson E, Ahonen J, Hâyry P: CMV infection, class II antigen expression. and human kidney allograft rejection. Transplantation 1986:42:364-367.
6. Tourkantonis A, Lazaridis A: Interaction between cytomegalovirus infection and renal transplant rejection. Kidney Int 1983;23(suppl 14):46-49.
7. Niaudet P, Raguin G, Lefcvsc J-J, Busson M, Cabau N, Fortier B, Boue A, Broyer M, Bedros-sian J, Fries D. Kreis H, Sracr J-D: Serological status of cytomegalovirus and outcome of renal transplantation. Kidney Int 1983:23(suppl 14): 50-53.
8. Ranjan D, Burke G, Esquenazi V, Milgrom M, Koleilat N, Roth D, Gomez C, Olson L, Ba-bischkin S, Gharagozloo H, Miller J: Factors affecting the ten-year oucomc of human renal allografts: The effect of viral infections. Transplantation 1991:51:113-117.
9. Winston DJ, Ho WB, Lin C-H, Bartoni K, Budinger M, Gale RP, Champlin RE: Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 1987;106:12-18.
10. Steinmuller DR, Grancto D, Swift C, Novick AC, Streem SB, Cunningham RJ, Hodge E, Bretan P: Use of intravenous immunoglobulin prophylaxis for cytomegalovirus infection post living-related donor renal transplantation. Transplant Proc 1989:21:2069-2071.
11. Chchimi J, Peppard J, Emanuel D: Selection of an intravenous immunoglobulin for the immu-noprophvlaxis of cytomegalovirus infections: An in vitro comparison of currently available and previously effective immune globulins. Bone Marrow Transplant 1987:2:395-402.
12. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58:259-263.
13. Stagno S, Britt WJ, Pass RF: Cytomegalovirus; in Schmidt NJ. Emmons RW (eds): Diagnostic Procedures for Viral. Rickettsial and Chlamydial Infections, ed 6. Washington, American Public Health Association. 1989. pp 321-378.
14. Fine RN, Salusky IB, Ettengcr RB: The therapeutic approach to the infant, child and adolescent with end-stage renal disease. Pediatr Clin North Am 1987;34:789-801.
15. Ahou YC, Cecka JM: Effect of age on kidney transplants: in Terasaki P (ed): Clinical Transplant 1989. Los Angeles, UCLA Tissue Typing Laboratory. 1989. pp 369-378.
16. Pirsch JD, D'alessandro AM, Sollinger HW, Hoffmann RM, Roecker E, Voss BJ, Lorentzen D, Knechtle SJ, Reed A, Kalayoglu M, Beizer FO: The effect of donor age, recipient age. and HLA match on immunologic graft survival in cadaver renal transplant recipients. Transplantation 1992:53:55-59.
17. Drachman R, Schlesinger M, Shapira H, Druk-ker A: The immune status of uremic children/ adolescents with chronic renal failure and renal replacement therapy. Pediatr Nephrol 1989:3: 305-308.
18. Ettengcr RB, Blifeld C, Prince H, Gradus DB-E, Cho S, Sckiya N, Salusky IB, Fine RN: The pediatric nephrologist’s dilemma: Growth after renal transplantation and its interaction with age as a possible immunologic variable. J Pe-diatr 1987;111:1022-1025.
19. Ettenger RB, Rosenthal JT, Marik JL, Malek-zadeh M, Forsythe SB, Kamil ES, Salusky IB, Fine RN: Improved cadaveric renal transplant outcome in children. Pediatr Nephrol 1991:1: 137-142.
20. Harmon WE, Jabs K: Special issues in pediatric renal transplantation. Semin Nephrol 1992: 12:353-363.
21. Lynficld R, Herrin JT, Rubin RH: Varicella in pediatric renal transplant recipients. Pediatrics 1992:90:216-220.
22. Iragorri S, Pillay D, Serine M, Trompeter RS, Rees L, Griffiths PD: Prospective cytomegalovirus surveillance in pediatric renal transplant patients. Pediatr Nephrol 1993;7:55-60.
23. Burd RS, Gillingham KJ, Farber MS, Statz CL, Kramer MS, Najarian JS, Dunn DL: Diagnosis and treatment of cytomegalovirus disease in pediatric renal transplant recipients. J Pediatr Surg 1994;29:1049-1054.
24. Smiley ML, Wlodaver CG, Grossman RA, Barker CF, Pcrloff LJ, Tustin NB, Starr SE, Plotkin SA, Friedman HM: The role of pre-transplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation 1985:40:157-161.
25. Fine RN, Gruskin CM, Anand S, Licberman E, Wright HT: Cytomegalovirus in children: Post-renal transplantation. Am J Dis Child 1970; 120:197-202.
26. Trachtman H, Weiss RA, Spigland I, Greifer I: Clinical manifestations of herpesvirus infections in pediatric renal transplant recipients. Pediatr Infect Dis J 1985;4:480-486.
27. Syndman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Lirkman RL, Milford EL, Cho SI, Bush HL, Levey RH, Harmon WE, Zimmerman CE, Shapiro ME, Stcinman T, Lo-Gcrfo F, Idelson B, Schröter GPJ, Levin MJ, Mclver J, Lcszczynski J, Grady GF: Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 1987:317:1049-1054.
28. Condie RM, O’reilly RJ: Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous. hyperimmune cytomegalovirus globulin. Birth Defects 1984;20:327-344.
29. Sherlock CH, Denegrí JF, Ashley RL: Serological responses to cytomegalovirus during renal transplant rejection. Transplantation 1991:52: 272-275.
30. Bia MK, Andiman W, Gaudio K, Kliger A, Sigel N, Smith D, Flye W: Effect of treatment with cyclosporine versus azathioprinc on incidence and severity of cytomegalovirus infection posttransplantation. Transplantation 1985.40:610-614.
31. Rubin RH: Infection in the renal and liver transplant patient; in Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host, ed 2. New York, Plenum Publishing. 1988. pp 557-621.
32. Prokarat S, Drabik E, Grenda R, Vogt E: Ganciclovir in cytomegalovirus prophylaxis in high-risk pediatric renal transplant recipients. Transplant Proc 1993:25:2577.